From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Gastroenterology>
  4. Summary and Comment

Is Endoscopic Surveillance of Gastric Ulcers Cost-Effective?

Probably not, unless the prevalence of undetected malignancy exceeds 6%

The practice of proving that a gastric ulcer is healed to rule out malignancy is a holdover from the days of barium studies. This strategy nevertheless remains common, despite multiple analyses that have shown its value to be minimal. Now, investigators have evaluated the long-term costs and benefits of using endoscopic surveillance of gastric ulcers to detect malignancy. They used a Markov decision-analytic model with inputs from clinical and epidemiologic studies.

The base-case cohort comprised 60-year-old men with presumed-benign gastric ulcers and a 2.6% prevalence of undetected malignancy. In this group, the lifetime risk for gastric cancer was estimated to be 4.4%. Follow-up endoscopic surveillance to document healing increased life expectancy by 10 days and increased quality-adjusted life expectancy by 2.6 days at a cost of US$146,700 per quality-adjusted life year (QALY). Sensitivity analysis showed that increasing the prevalence of undetected cancers or decreasing the cost of endoscopy could reduce the cost per QALY. The probability that surveillance would cost less than $100,000 per QALY was 25%. The authors concluded that unless the prevalence of undetected cancer exceeds 6%, surveillance is unlikely to be cost-effective; however, it might still be appropriate in high-risk patients.

Comment: The assumptions used in decision-analytic models can always be questioned. This study's findings, consistent with those from previous analyses, demonstrate that universal surveillance for malignancy in endoscopically diagnosed gastric ulcers has a low yield and a high cost. Pursuing such an approach is simply untenable in an era of limited healthcare resources. A better approach to ruling out malignancy in gastric ulcers is to ensure careful endoscopic and histological evaluation at the time of the index endoscopy.

David J. Bjorkman, MD, MSPH (HSA), SM (Epid.)

Published in Journal Watch Gastroenterology July 30, 2010

Citation(s):

Yeh JM et al. Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival. Gastrointest Endosc 2010 Jul; 72:33.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2010. Massachusetts Medical Society. All rights reserved.